A detailed history of Cibc Asset Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 113,822 shares of MRNA stock, worth $4.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
113,822
Previous 107,028 6.35%
Holding current value
$4.19 Million
Previous $12.7 Million 40.15%
% of portfolio
0.03%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$63.64 - $125.14 $432,370 - $850,201
6,794 Added 6.35%
113,822 $7.61 Million
Q2 2024

Aug 01, 2024

BUY
$101.21 - $166.61 $127,220 - $209,428
1,257 Added 1.19%
107,028 $12.7 Million
Q1 2024

May 09, 2024

BUY
$85.37 - $115.44 $515,549 - $697,142
6,039 Added 6.06%
105,771 $11.3 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $43,513 - $65,373
626 Added 0.63%
99,732 $9.92 Million
Q3 2023

Oct 30, 2023

BUY
$96.41 - $126.61 $915,220 - $1.2 Million
9,493 Added 10.59%
99,106 $10.2 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $64,582 - $87,488
-545 Reduced 0.6%
89,613 $10.9 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $136,609 - $198,399
-1,007 Reduced 1.1%
90,158 $13.8 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $251,083 - $445,494
-2,121 Reduced 2.27%
91,165 $16.4 Million
Q3 2022

Nov 03, 2022

BUY
$118.07 - $194.18 $325,046 - $534,577
2,753 Added 3.04%
93,286 $11 Million
Q2 2022

Aug 09, 2022

BUY
$117.13 - $176.59 $57,862 - $87,235
494 Added 0.55%
90,533 $12.9 Million
Q1 2022

May 06, 2022

SELL
$126.46 - $235.05 $71,829 - $133,508
-568 Reduced 0.63%
90,039 $15.5 Million
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $1.73 Million - $2.82 Million
7,651 Added 9.22%
90,607 $23 Million
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $6.76 Million - $14.7 Million
30,443 Added 57.97%
82,956 $31.9 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $258,520 - $467,610
1,990 Added 3.94%
52,513 $12.3 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $788,497 - $1.34 Million
7,222 Added 16.68%
50,523 $6.62 Million
Q4 2020

Feb 03, 2021

BUY
$65.74 - $169.86 $277,094 - $715,959
4,215 Added 10.78%
43,301 $4.52 Million
Q3 2020

Nov 05, 2020

BUY
$54.34 - $94.85 $1.46 Million - $2.55 Million
26,903 Added 220.82%
39,086 $2.77 Million
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $169,709 - $259,254
12,183 New
12,183 $238,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.